Insulin Degludec and Insulin Aspart Injection

DRUG2 trials

Sponsors

Beijing Hospital, Yanbing Li

Conditions

Type 2 DiabetesType 2 Diabetes Mellitus

Phase 4

Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 Diabetes

Not yet recruitingNCT07173712

Yanbing LiType 2 Diabetes

Start: 2026-03-15End: 2027-12-31Target: 324Updated: 2026-02-06

Unknown Phase

Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T2DM

CompletedNCT05417841

Beijing HospitalType 2 Diabetes Mellitus

Start: 2023-03-23End: 2025-08-15Updated: 2025-12-03